Blank Rome partner Erica R. Graves will serve as a speaker at Food & Drug Law Institute's Enforcement, Litigation, and Compliance Conference: For the Drug, Device, Food, and Tobacco Industries, being held December 4 through 5, 2025, in Washington, D.C., and virtually.
ABOUT THE CONFERENCE
This annual event brings together industry regulators, attorneys, litigators, academics, consultants, and other stakeholders to discuss trends and issues in enforcement and compliance. Hear from and interact with top officials from FDA, DOJ, FTC, and other government agencies, and gain valuable insights into the latest developments in both civil and criminal litigation, and recent cases and settlements.
Erica's session, "State-Level Challenges and Initiatives Amid FDA Enforcement Discretion," will take place on Friday, December 5, from 10:20 a.m. to 11:20 a.m.
ABOUT THE SESSION
This session explores the impact of state-level initiatives that arise when FDA exercises enforcement discretion. Topics include recent state laws on PFAS in packaging, Extended Producer Responsibility (EPR) and composability labeling mandates, and expanded state enforcement on greenwashing, ingredient disclosures, and nicotine sales—including proposed vape bans and retail restrictions. The discussion will also address key Section 310(a) preemption rulings on state efforts to enforce FDCA provisions via consumer protection or false advertising laws.
Speakers:
- Erica Graves, Partner, Blank Rome LLP
- Meaghan Hembree, Partner, Holland & Knight LLP
- Samuel D. Jockel, Partner, Alston & Bird LLP
- Tony Subketkaew, Assistant General Counsel, General Mills, Inc.
Other sessions on Friday include:
- FDLI Welcome and New Rules, New Risks: Inside the Changing World of Federal Inspections
- Beyond the Rule: What to Watch in FDA’s QMSR Transition
- Custom Meds, Custom Risks: Compounding Litigation and Enforcement
- Enforcement on Trial: Recent Court Decisions Impacting FDA’s Authority
For more information and to register, please visit the event webpage.
